Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The changing therapeutic landscape of head and neck cancer.
Cramer JD, Burtness B, Le QT, Ferris RL. Cramer JD, et al. Among authors: burtness b. Nat Rev Clin Oncol. 2019 Nov;16(11):669-683. doi: 10.1038/s41571-019-0227-z. Epub 2019 Jun 12. Nat Rev Clin Oncol. 2019. PMID: 31189965 Review.
Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, Wilson LD, Haffty BG, Son YH, Ross DA, Weinberger PM, Chung GG, Zelterman D, Burtness BA, Cooper DL. Psyrri A, et al. Among authors: burtness ba. J Clin Oncol. 2004 Aug 1;22(15):3061-9. doi: 10.1200/JCO.2004.01.108. J Clin Oncol. 2004. PMID: 15284256 Clinical Trial.
Oropharyngeal cancer.
Psyrri A, Prezas L, Burtness B. Psyrri A, et al. Among authors: burtness b. Clin Adv Hematol Oncol. 2008 Aug;6(8):604-12. Clin Adv Hematol Oncol. 2008. PMID: 18820604 Review.
Targeting EGFR resistance networks in head and neck cancer.
Ratushny V, Astsaturov I, Burtness BA, Golemis EA, Silverman JS. Ratushny V, et al. Cell Signal. 2009 Aug;21(8):1255-68. doi: 10.1016/j.cellsig.2009.02.021. Epub 2009 Mar 1. Cell Signal. 2009. PMID: 19258037 Free PMC article. Review.
Head and neck cancer.
Psyrri A, Burtness B, Harari PM, Vermorken JB, Licitra L, Sasaki CT. Psyrri A, et al. Among authors: burtness b. J Oncol. 2009;2009:358098. doi: 10.1155/2009/358098. Epub 2010 Feb 4. J Oncol. 2009. PMID: 20169126 Free PMC article. No abstract available.
Nuclear localization of signal transducer and activator of transcription 3 in head and neck squamous cell carcinoma is associated with a better prognosis.
Pectasides E, Egloff AM, Sasaki C, Kountourakis P, Burtness B, Fountzilas G, Dafni U, Zaramboukas T, Rampias T, Rimm D, Grandis J, Psyrri A. Pectasides E, et al. Among authors: burtness b. Clin Cancer Res. 2010 Apr 15;16(8):2427-34. doi: 10.1158/1078-0432.CCR-09-2658. Epub 2010 Apr 6. Clin Cancer Res. 2010. PMID: 20371693 Free PMC article.
Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-and neck-cancer.
Turaka A, Li T, Nicolaou N, Lango MN, Burtness B, Horwitz EM, Ridge JA, Feigenberg SJ. Turaka A, et al. Among authors: burtness b. Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):65-70. doi: 10.1016/j.ijrobp.2009.10.034. Epub 2010 Apr 10. Int J Radiat Oncol Biol Phys. 2011. PMID: 20385457 Free PMC article.
269 results